Anti-CD3/MUC1-armed cytokine induced killer cells

N/A

Report date: 2026/03/19 16:46:35

Base Information

Drug NameAnti-CD3/MUC1-armed cytokine induced killer cells
Drug Alias NameAnti-CD3/MUC1-armed PD-1 inhibitor-induced CIK cellsPD-1 activated CIK armed with anti-CD3/Anti-MUC1 bispecific antibodyActivated CIK armed with anti-CD3-MUC1/CEA/EpCAM/GPC3 bispecific antibodyAnti-CD3/MUC1-armed cytokine induced killer cells - Benhealth BiopharmaceuticalAnti-CD3/MUC1 antibody-armed PD-1 inhibitor-induced cytokine-induced killer cells +[6] 
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell
Mechanisms of ActionCell replacementsCD3 T-cell engagersMucin-1 inhibitors
TargetsMucin-1T cell surface glycoprotein CD3
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsLiver Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesBenhealth Biopharmaceutical (Shenzhen) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBenhealth Biopharmaceutical (Shenzhen) Co Ltd
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsLiver Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A